Doctor profile · Federal record
Dr. Adolfo Diaz Duque, MD
Medical Oncology Physician (CMS: Hematology/Oncology) · Hematology (Internal Medicine) Physician · Hematology & Oncology Physician · Internal Medicine Physician · Hospitalist Physician · San Antonio, TX
- NPI 1730463324
- Accepts Medicare
- MIPS 89.6 / 100 · 2023
- 25 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
7979 Wurzbach RD
San Antonio, TX 782294427
(210) 450-1143
fax (210) 450-0407 - Additional location
-
720 Pleasanton RD
San Antonio, TX 782141306
(210) 921-3800
Credentials & registration
- NPI registered
- September 2011 — 15 yrs on file
- Profile last updated
- April 9, 2026
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Texas #P0374
- Medicaid
- TX #288987503
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1730463324. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
18,136
Distinct HCPCS
10
Medicare allowed
$488,675
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 7,200 | 20 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 4,200 | 24 | $0 | |
J9030 |
Bcg live intravesical instillation, 1 mg | 2,459 | 27 | $3 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 1,032 | 47 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 984 | 56 | $0 | |
J9190 |
Injection, fluorouracil, 500 mg | 315 | 15 | $2 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 280 | 24 | $1 | |
J9201 |
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 217 | 17 | $3 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 196 | 88 | $124 | |
96375 |
Injection of additional new drug or substance into vein | 183 | 71 | $15 |
In context: peer comparison
Among 19 peers in San Antonio Medical Oncology Physician, average services per provider: 585. This provider delivers 31× the peer median.Open Payments
Industry payments received
All-time total
$92,860
Transactions
72
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Adc Therapeutics America, INC. | 33 | $40,814.44 | |
| Incyte Corporation | 20 | $24,598.49 | |
| AstraZeneca Pharmaceuticals Lp | 9 | $13,596.38 | |
| Genentech USA, INC. | 8 | $12,074.65 | |
| MorphoSys, US INC. | 1 | $1,740.00 | |
| Regeneron Pharmaceuticals, INC. | 1 | $36.08 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
340
Patients
47
Total drug cost
$2,418,007
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Valacyclovir (Valacyclovir Hcl) | Brand | 61 | 19 | $3,150 |
| Calquence (Acalabrutinib Maleate) | Brand | 60 | 0 | $880,919 |
| Imbruvica (Ibrutinib) | Brand | 35 | 0 | $629,441 |
| Ondansetron Hcl | Generic | 26 | 15 | $1,322 |
| Prochlorperazine Maleate | Generic | 25 | 13 | $1,211 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 24 | 0 | $143 |
| Brukinsa (Zanubrutinib) | Brand | 23 | 0 | $337,643 |
| Prednisone | Generic | 23 | 0 | $152 |
| Revlimid (Lenalidomide) | Brand | 22 | 0 | $404,315 |
| Tasigna (Nilotinib Hcl) | Brand | 16 | 0 | $159,370 |
Hospital affiliations
Frequently asked questions
What is Dr. Adolfo Diaz Duque's medical specialty?
Dr. Adolfo Diaz Duque practices Medical Oncology Physician in San Antonio, TX.
Where does Dr. Adolfo Diaz Duque practice?
Dr. Adolfo Diaz Duque practices at 7979 Wurzbach RD, San Antonio, TX 782294427. Office phone: 2104501143.
What is Dr. Adolfo Diaz Duque's NPI?
Dr. Adolfo Diaz Duque's National Provider Identifier (NPI) is 1730463324, issued by NPPES.
Does Dr. Adolfo Diaz Duque accept Medicare assignment?
Yes. Dr. Adolfo Diaz Duque accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Adolfo Diaz Duque commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453); Bcg live intravesical instillation, 1 mg (HCPCS J9030). Source: CMS Medicare Physician & Other Practitioners file.